Q2 Total Revenue Grew 31% Year-Over-Year to Approximately $49.6 Million
Q2 Adjusted EBITDA Exceeding 5.0% of Revenue
Cash Position Remains Strong at Over $18.0 Million
VANCOUVER, BC, July 7, 2025 /CNW/ – Kits Eyecare Ltd. (TSX:KITS) (“KITS” or the “Company”), the leading vertically integrated eyecare provider, is providing selected preliminary unaudited results for its second quarter ended June 30, 2025.
Select Preliminary Second Quarter 2025 Financial Highlights:
- Total Revenue grew 31.0% year-over-year to approximately $49.6 million.
- Adjusted EBITDA increased year-over-year to exceed 5.0% of Revenue.
- New customers increased year-over-year by 55.0%.
- Cash position remains strong at over $18.0 million.
The Company looks forward to reporting its full second quarter 2025 results in early August 2025. Details for the second quarter 2025 conference call will be disclosed in …